FOX vs HALO · P/E 13, $24.49B cap vs P/E 15, rev $857.7M
Fox Corp Class B (FOX) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
FOX does not have a complete income-statement cache yet.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the FOX and HALO stock pages for the full models.
Not investment advice.